Zdrowie i gospodarka · 13/04/2023
FDA Exempts Certain Biological Products from Reporting Requirements
The FDA is exempting two categories of biological products from annual reporting requirements under the FD&C Act, citing that applying these requirements is not necessary to protect public health.
Source: Federal Register — Food and Drug AdministrationOpen original release →